Loading…
Loading…
When do you think the growth products could overtake the legacy franchises
Could you remind us whether there's a similar interim in AHEAD 3-45 and maybe more broadly discuss the differences in design between AHEAD 3-45 and TRAILBLAZER-ALZ 3
In Q4, revenue was up 30%, but the revenue recognized was only up $1 million. Can you talk about the dynamics behind that?
could you give us some sense of the breakdown between KESJEVRI and Genomics in that number
Can you give us a sense of where it currently is and where it could be in 2026
can you give us some sense of will the prescription data that we see from third-party sources be accurate
on ALYFTREK, there is a dispute going on between you and Royalty Pharma as to exactly what Royalty is owed